Kenneth Bilchick, MD, a UVA Health heart rhythm specialist who co-led the study along with Tiago Palmisano, MD, and David Guarraia, MD, explained, The survival curves in all three groups indicated that there was a reduction in the risk of incident atrial fibrillation regardless of whether you gained weight, lost a little weight, or lost a lot of weight. Among the medicines studied, semaglutide showed the strongest association with reduced Afib risk
This cumulative effect means that even brief excursions, repeated over time, can significantly reduce actual shelf life
Semaglutide is sold under the brand names Ozempic and Rybelsus
New or worsening cognitive symptoms after starting a GLP-1 medication require prompt evaluation
primary-cta Brand-Name Access: Edens Premium Tier Eden gives patients access to FDA-approved brand-name medications when prescribed by a licensed healthcare provider